1 Introduction to Research & Analysis Reports 1.1 Diphtheria, Pertussis, and Tetanus Vaccine Market Definition 1.2 Market Segments 1.2.1 Segment by Type 1.2.2 Segment by Application 1.3 China Diphtheria, Pertussis, and Tetanus Vaccine Market Overview 1.4 Methodology & Sources of Information 1.4.1 Research Methodology 1.4.2 Research Process 1.4.3 Base Year 2 China Diphtheria, Pertussis, and Tetanus Vaccine Overall Market Size 2.1 China Diphtheria, Pertussis, and Tetanus Vaccine Market Size: 2021 VS 2027 2.2 China Diphtheria, Pertussis, and Tetanus Vaccine Revenue, Prospects & Forecasts: 2016-2027 2.3 China Diphtheria, Pertussis, and Tetanus Vaccine Sales: 2016-2027 3 Company Landscape 3.1 Top Diphtheria, Pertussis, and Tetanus Vaccine Players in China Market 3.2 Top China Diphtheria, Pertussis, and Tetanus Vaccine Companies Ranked by Revenue 3.3 China Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Companies 3.4 China Diphtheria, Pertussis, and Tetanus Vaccine Sales by Companies 3.5 China Diphtheria, Pertussis, and Tetanus Vaccine Price by Manufacturer (2016-2021) 3.6 Top 3 and Top 5 Diphtheria, Pertussis, and Tetanus Vaccine Companies in China Market, by Revenue in 2020 3.7 Manufacturers Diphtheria, Pertussis, and Tetanus Vaccine Product Type 3.8 Tier 1, Tier 2 and Tier 3 Diphtheria, Pertussis, and Tetanus Vaccine Players in China Market 3.8.1 List of Tier 1 Diphtheria, Pertussis, and Tetanus Vaccine Companies in China 3.8.2 List of Tier 2 and Tier 3 Diphtheria, Pertussis, and Tetanus Vaccine Companies in China 4 Sights by Type 4.1 Overview 4.1.1 By Type - China Diphtheria, Pertussis, and Tetanus Vaccine Market Size Markets, 2021 & 2027 4.1.2 DTaP 4.1.3 Td 4.1.4 Tdap 4.2 By Type - China Diphtheria, Pertussis, and Tetanus Vaccine Revenue & Forecasts 4.2.1 By Type - China Diphtheria, Pertussis, and Tetanus Vaccine Revenue, 2016-2021 4.2.2 By Type - China Diphtheria, Pertussis, and Tetanus Vaccine Revenue, 2022-2027 4.2.3 By Type - China Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share, 2016-2027 4.3 By Type - China Diphtheria, Pertussis, and Tetanus Vaccine Sales & Forecasts 4.3.1 By Type - China Diphtheria, Pertussis, and Tetanus Vaccine Sales, 2016-2021 4.3.2 By Type - China Diphtheria, Pertussis, and Tetanus Vaccine Sales, 2022-2027 4.3.3 By Type - China Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share, 2016-2027 4.4 By Type - China Diphtheria, Pertussis, and Tetanus Vaccine Price (Manufacturers Selling Prices), 2016-2027 5 Sights by Application 5.1 Overview 5.1.1 By Application - China Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2021 & 2027 5.1.2 Hospitals 5.1.3 Clinics 5.1.4 Vaccination Centers 5.2 By Application - China Diphtheria, Pertussis, and Tetanus Vaccine Revenue & Forecasts 5.2.1 By Application - China Diphtheria, Pertussis, and Tetanus Vaccine Revenue, 2016-2021 5.2.2 By Application - China Diphtheria, Pertussis, and Tetanus Vaccine Revenue, 2022-2027 5.2.3 By Application - China Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share, 2016-2027 5.3 By Application - China Diphtheria, Pertussis, and Tetanus Vaccine Sales & Forecasts 5.3.1 By Application - China Diphtheria, Pertussis, and Tetanus Vaccine Sales, 2016-2021 5.3.2 By Application - China Diphtheria, Pertussis, and Tetanus Vaccine Sales, 2022-2027 5.3.3 By Application - China Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share, 2016-2027 5.4 By Application - China Diphtheria, Pertussis, and Tetanus Vaccine Price (Manufacturers Selling Prices), 2016-2027 6 Manufacturers & Brands Profiles 6.1 Johnson & Johnson 6.1.1 Johnson & Johnson Corporation Information 6.1.2 Johnson & Johnson Overview 6.1.3 Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Sales and Revenue in China Market (2016-2021) 6.1.4 Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Product Description 6.1.5 Johnson & Johnson Recent Developments 6.2 GlaxoSmithKline 6.2.1 GlaxoSmithKline Corporation Information 6.2.2 GlaxoSmithKline Overview 6.2.3 GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Sales and Revenue in China Market (2016-2021) 6.2.4 GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Product Description 6.2.5 GlaxoSmithKline Recent Developments 6.3 Sanofi 6.3.1 Sanofi Corporation Information 6.3.2 Sanofi Overview 6.3.3 Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Sales and Revenue in China Market (2016-2021) 6.3.4 Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Product Description 6.3.5 Sanofi Recent Developments 6.4 Lanzhou Institute of Biological 6.4.1 Lanzhou Institute of Biological Corporation Information 6.4.2 Lanzhou Institute of Biological Overview 6.4.3 Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Sales and Revenue in China Market (2016-2021) 6.4.4 Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Product Description 6.4.5 Lanzhou Institute of Biological Recent Developments 6.5 Merck 6.5.1 Merck Corporation Information 6.5.2 Merck Overview 6.5.3 Merck Diphtheria, Pertussis, and Tetanus Vaccine Sales and Revenue in China Market (2016-2021) 6.5.4 Merck Diphtheria, Pertussis, and Tetanus Vaccine Product Description 6.5.5 Merck Recent Developments 6.6 Novartis 6.6.1 Novartis Corporation Information 6.6.2 Novartis Overview 6.6.3 Novartis Diphtheria, Pertussis, and Tetanus Vaccine Sales and Revenue in China Market (2016-2021) 6.6.4 Novartis Diphtheria, Pertussis, and Tetanus Vaccine Product Description 6.6.5 Novartis Recent Developments 6.7 AstraZeneca 6.7.1 AstraZeneca Corporation Information 6.7.2 AstraZeneca Overview 6.7.3 AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Sales and Revenue in China Market (2016-2021) 6.7.4 AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Product Description 6.7.5 AstraZeneca Recent Developments 6.8 Emergent 6.8.1 Emergent Corporation Information 6.8.2 Emergent Overview 6.8.3 Emergent Diphtheria, Pertussis, and Tetanus Vaccine Sales and Revenue in China Market (2016-2021) 6.8.4 Emergent Diphtheria, Pertussis, and Tetanus Vaccine Product Description 6.8.5 Emergent Recent Developments 6.9 Astellas 6.9.1 Astellas Corporation Information 6.9.2 Astellas Overview 6.9.3 Astellas Diphtheria, Pertussis, and Tetanus Vaccine Sales and Revenue in China Market (2016-2021) 6.9.4 Astellas Diphtheria, Pertussis, and Tetanus Vaccine Product Description 6.9.5 Astellas Recent Developments 7 China Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity, Analysis 7.1 China Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity, 2016-2027 7.2 Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity of Key Manufacturers in China Market 8 Key Market Trends, Opportunity, Drivers and Restraints 8.1 Market Opportunities & Trends 8.2 Market Drivers 8.3 Market Restraints 9 Diphtheria, Pertussis, and Tetanus Vaccine Supply Chain Analysis 9.1 Diphtheria, Pertussis, and Tetanus Vaccine Industry Value Chain 9.2 Diphtheria, Pertussis, and Tetanus Vaccine Upstream Market 9.3 Diphtheria, Pertussis, and Tetanus Vaccine Downstream and Clients 9.4 Marketing Channels Analysis 9.4.1 Marketing Channels 9.4.2 Diphtheria, Pertussis, and Tetanus Vaccine Distributors and Sales Agents in China Market 10 Conclusion 11 Appendix 11.1 Note 11.2 Examples of Clients 11.3 Author Details 11.4 Disclaimer

List of Tables Table 1. Key Players of Diphtheria, Pertussis, and Tetanus Vaccine in China Market Table 2. Top Diphtheria, Pertussis, and Tetanus Vaccine Players in China Market, Ranking by Revenue (2019) Table 3. China Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Companies, (US$, Mn), 2016-2021 Table 4. China Diphtheria, Pertussis, and Tetanus Vaccine Revenue Share by Companies, 2016-2021 Table 5. China Diphtheria, Pertussis, and Tetanus Vaccine Sales by Companies, (K MT), 2016-2021 Table 6. China Diphtheria, Pertussis, and Tetanus Vaccine Sales Share by Companies, 2016-2021 Table 7. Key Manufacturers Diphtheria, Pertussis, and Tetanus Vaccine Price (2016-2021) & (USD/MT) Table 8. Manufacturers Diphtheria, Pertussis, and Tetanus Vaccine Product Type Table 9. List of Tier 1 Diphtheria, Pertussis, and Tetanus Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share Table 10. List of Tier 2 and Tier 3 Diphtheria, Pertussis, and Tetanus Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share Table 11. Major Manufacturers of DTaP Table 12. Major Manufacturers of Td Table 13. By Type – China Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2021 & 2027 Table 14. By Type - China Diphtheria, Pertussis, and Tetanus Vaccine Revenue (US$, Mn), 2016-2021 Table 15. By Type - China Diphtheria, Pertussis, and Tetanus Vaccine Revenue (US$, Mn), 2022-2027 Table 16. By Type - China Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), 2016-2021 Table 17. By Type - China Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), 2022-2027 Table 18. By Application – China Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2021 VS 2027 Table 19. By Application - China Diphtheria, Pertussis, and Tetanus Vaccine Revenue (US$, Mn), 2016-2021 Table 20. By Application - China Diphtheria, Pertussis, and Tetanus Vaccine Revenue (US$, Mn), 2022-2027 Table 21. By Application - China Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), 2016-2021 Table 22. By Application - China Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), 2022-2027 Table 23. Johnson & Johnson Corporation Information Table 24. Johnson & Johnson Description and Major Businesses Table 25. Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021) Table 26. Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Product Table 27. Johnson & Johnson Recent Developments Table 28. GlaxoSmithKline Corporation Information Table 29. GlaxoSmithKline Description and Major Businesses Table 30. GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021) Table 31. GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Product Table 32. GlaxoSmithKline Recent Developments Table 33. Sanofi Corporation Information Table 34. Sanofi Description and Major Businesses Table 35. Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021) Table 36. Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Product Table 37. Sanofi Recent Developments Table 38. Lanzhou Institute of Biological Corporation Information Table 39. Lanzhou Institute of Biological Description and Major Businesses Table 40. Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021) Table 41. Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Product Table 42. Lanzhou Institute of Biological Recent Developments Table 43. Merck Corporation Information Table 44. Merck Description and Major Businesses Table 45. Merck Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021) Table 46. Merck Diphtheria, Pertussis, and Tetanus Vaccine Product Table 47. Merck Recent Developments Table 48. Novartis Corporation Information Table 49. Novartis Description and Major Businesses Table 50. Novartis Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021) Table 51. Novartis Diphtheria, Pertussis, and Tetanus Vaccine Product Table 52. Novartis Recent Developments Table 53. AstraZeneca Corporation Information Table 54. AstraZeneca Description and Major Businesses Table 55. AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021) Table 56. AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Product Table 57. AstraZeneca Recent Developments Table 58. Emergent Corporation Information Table 59. Emergent Description and Major Businesses Table 60. Emergent Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021) Table 61. Emergent Diphtheria, Pertussis, and Tetanus Vaccine Product Table 62. Emergent Recent Developments Table 63. Astellas Corporation Information Table 64. Astellas Description and Major Businesses Table 65. Astellas Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021) Table 66. Astellas Diphtheria, Pertussis, and Tetanus Vaccine Product Table 67. Astellas Recent Developments Table 68. Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity (K MT) of Key Manufacturers in China Market, 2019-2021 (K MT) Table 69. China Diphtheria, Pertussis, and Tetanus Vaccine Capacity Market Share of Key Manufacturers, 2019-2021 Table 70. Diphtheria, Pertussis, and Tetanus Vaccine Market Opportunities & Trends in China Market Table 71. Diphtheria, Pertussis, and Tetanus Vaccine Market Drivers in China Market Table 72. Diphtheria, Pertussis, and Tetanus Vaccine Market Restraints in China Market Table 73. Diphtheria, Pertussis, and Tetanus Vaccine Raw Materials Table 74. Diphtheria, Pertussis, and Tetanus Vaccine Raw Materials Suppliers in China Market Table 75. Typical Diphtheria, Pertussis, and Tetanus Vaccine Downstream Table 76. Diphtheria, Pertussis, and Tetanus Vaccine Downstream Clients in China Market Table 77. Diphtheria, Pertussis, and Tetanus Vaccine Distributors and Sales Agents in China Market List of Figures Figure 1. Diphtheria, Pertussis, and Tetanus Vaccine Product Picture Figure 2. Diphtheria, Pertussis, and Tetanus Vaccine Segment by Type Figure 3. Diphtheria, Pertussis, and Tetanus Vaccine Segment by Application Figure 4. China Diphtheria, Pertussis, and Tetanus Vaccine Market Overview: 2020 Figure 5. China Diphtheria, Pertussis, and Tetanus Vaccine Market Size: 2021 VS 2027 (US$, Mn) Figure 6. China Diphtheria, Pertussis, and Tetanus Vaccine Revenue, 2016-2027 (US$, Mn) Figure 7. Diphtheria, Pertussis, and Tetanus Vaccine Sales in China Market: 2016-2027 (K MT) Figure 8. The Top 3 and 5 Players Market Share by Diphtheria, Pertussis, and Tetanus Vaccine Revenue in 2020 Figure 9. DTaP Product Picture Figure 10. Td Product Picture Figure 11. Tdap Product Picture Figure 12. By Type - China Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share, 2016-2027 Figure 13. By Type - China Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share, 2016-2027 Figure 14. By Type - China Diphtheria, Pertussis, and Tetanus Vaccine Price (USD/MT), 2016-2027 Figure 15. Hospitals Figure 16. Clinics Figure 17. Vaccination Centers Figure 18. By Application - China Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share, 2016-2027 Figure 19. By Application - China Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share, 2016-2027 Figure 20. By Application - China Diphtheria, Pertussis, and Tetanus Vaccine Price (USD/MT), 2016-2027 Figure 21. Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 22. GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 23. Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 24. Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 25. Merck Diphtheria, Pertussis, and Tetanus Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 26. Novartis Diphtheria, Pertussis, and Tetanus Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 27. AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 28. Emergent Diphtheria, Pertussis, and Tetanus Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 29. Astellas Diphtheria, Pertussis, and Tetanus Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 30. China Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity (K MT), 2016-2027 Figure 31. Diphtheria, Pertussis, and Tetanus Vaccine Industry Value Chain Figure 32. Marketing Channels

Johnson & Johnson GlaxoSmithKline Sanofi Lanzhou Institute of Biological Merck Novartis AstraZeneca Emergent Astellas